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1. Introduction {#s0005}
===============

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of the ongoing global pandemic of coronavirus disease 2019 (COVID-19) ([@bb0060]). The primary transmission routes of SARS-CoV-2 are inhalation of aerosols/droplets and person-to-person contact ([@bb0150]; [@bb0255]). There is increasing evidence for the fecal shedding of SARS-CoV-2 and the presence of viral RNA in domestic wastewater ([@bb0115]; [@bb0245]). Therefore, the presence of SARS-CoV-2 RNA in untreated wastewater suggests that wastewater could be utilized as a tool to monitor for the invasion, prevalence, molecular epidemiology, and potential eradication of SARS-CoV-2 in the community in an approach known as wastewater-based epidemiology (WBE) ([@bb0115]).

The detection of SARS-CoV-2 RNA in untreated domestic wastewater has been reported in Australia ([@bb0020]), the Netherlands ([@bb0145]), USA ([@bb0230]; [@bb0160]), France ([@bb0235], [@bb0240]), China ([@bb0260]), Israel ([@bb0025]), Turkey ([@bb0120]), Spain ([@bb0170], [@bb0175]) and Italy ([@bb0125], [@bb0130]). The virus concentration methods used in these studies to recover SARS-CoV-2 RNA from wastewater include ultrafiltration, polyethylene glycol (PEG) precipitation, ultracentrifugation, and filtration with an electronegative membrane. Rapid, efficient (high recovery), and cost-effective virus concentration methods are needed to monitor SARS-CoV-2 and its nucleic acid in untreated wastewater samples for the successful application of WBE for COVID-19 surveillance. Accurate estimates of viral concentration in untreated wastewater require that the concentration observed by reverse transcription-quantitative polymerase chain reaction (RT-qPCR) assays be adjusted using the recovery efficiency of a particular combination of virus and concentration method.

The concentration methods used in each of the above studies were originally developed for the detection of nonenveloped enteric viruses, such as adenovirus, norovirus, and enterovirus in water/wastewater samples. Little is known about the recovery efficiencies for an enveloped virus such as SARS-CoV-2. The virus concentration recovery efficiencies of SARS-CoV-2 may be different from those of nonenveloped enteric viruses because of significant structural differences between enveloped viruses and nonenveloped enteric viruses. In a previous study, a head-to-head method comparison of virus recovery efficiencies demonstrated differences between an enveloped virus and a nonenveloped virus in lake water in Japan ([@bb0090]). Such discrepancies could lead to large errors (i.e., an order of magnitude) in the estimated concentration of SARS-CoV-2 in untreated wastewater.

To date, no information is available regarding the SARS-CoV-2 recovery efficiency for the wastewater concentration methods commonly used ([@bb0050]; [@bb0115]). Due to the stringent biosafety requirements of working with SARS-CoV-2, a model virus with similar structural and morphological characteristics provides a useful surrogate for estimating the recovery efficiency of SARS-CoV-2 concentration methods. A handful of non-human coronaviruses (CoVs), porcine epidemic diarrhea virus ([@bb0175]) and avian infectious bronchitis virus ([@bb0120]) have been used to estimate human CoV recoveries. Data suggested that approximately 11% and 3% of the seeded porcine epidemic diarrhea virus were recovered from untreated and treated wastewater, respectively, with aluminum flocculation-based concentration methods ([@bb0175]). Interestingly, these CoV recoveries were similar to the recoveries of the nonenveloped mengovirus ([@bb0175]), which is often used as a process control for enteric virus detection in environmental samples ([@bb0065]; [@bb0195]; [@bb0070]).

Murine hepatitis virus (MHV) is an enveloped and positive-sense single-stranded RNA *Betacoronavirus*, which belongs to the same genus as SARS-CoV-2 ([@bb0060]), and is responsible for a number of diseases in mice and rats ([@bb0180]). MHV has been used as a surrogate for human CoV in recovery and persistence studies ([@bb0250]). MHV and other murine viruses (e.g. murine norovirus) have been successfully used as surrogates for many different enveloped and nonenveloped viruses due to their structural and morphological similarities ([@bb0055]; [@bb0250]; [@bb0165]), and there are no special laboratory requirements for their use since they are non-pathogenic to humans.

In the present study, we evaluated the efficiencies of MHV recovery from wastewater using various virus concentration methods previously used to detect SARS-CoV-2 in wastewater ([@bb0020]; [@bb0145]; [@bb0230]). The performance of seven virus concentration methods was estimated and compared by seeding MHV in untreated wastewater samples. RT-qPCR assays were then used to determine MHV concentrations in seeded untreated domestic wastewater samples to identify the relative performance of each method for CoV recovery. The results presented in this study will allow researchers to select an appropriate efficient concentration method(s) for the recovery of SARS-CoV-2 from domestic wastewater for WBE applications.

2. Materials and methods {#s0010}
========================

2.1. Murine hepatitis virus (MHV) concentrations in fecal suspension {#s0015}
--------------------------------------------------------------------

The enveloped MHV stock was obtained from 20 fecal samples of naturally infected mice. Each MHV positive-fecal sample (approximately 250 mg) was suspended into 1 mL of phosphate buffered saline (1 × PBS) and then the samples were pooled together to produce a homogeneous fecal slurry. The slurry was centrifuged at 1000 *g* for 10 min. The pellet was discarded, and the supernatant was stored at −80 °C for three days. This supernatant, containing MHV, is referred to as the MHV suspension. The MHV RNA concentration in the fecal suspension was determined using an MHV RT-qPCR assay (see below for detailed methodologies). Briefly, RNA was directly extracted on three occasions from triplicate, 200 μL aliquots of MHV suspension using the RNeasy PowerMicrobiome Kit according to manufacturer instructions with a minor modification (Qiagen, Valencia, CA, USA). The glass beads in the bead tube were replaced with garnet beads which have sharp cutting edges.

2.2. Wastewater sample preparation {#s0020}
----------------------------------

A sample of untreated wastewater (2 L) was collected from a metropolitan wastewater treatment plant (WWTP) in Brisbane, Australia and transported to laboratory on ice. The wastewater sample was kept at 4 °C for 24 h. The WWTP treats domestic wastewater from approximately 325,000 people, as well as industrial wastewater. The treatment process consists of primary treatment, a secondary treatment (activated sludge), and disinfection with chlorine and UV. While stormwater also enters the WWTP, the study catchment did not receive any precipitation 24 h prior to the wastewater sampling. A 200-μL volume of MHV suspension was added to a 50-mL aliquot of untreated wastewater and subjected to each virus concentration method.

2.3. Virus concentration methods {#s0025}
--------------------------------

Viruses were concentrated from MHV seeded (*n* = 3) and unseeded (*n* = 1) domestic wastewater samples using each of the seven methods as shown in [Fig. 1](#f0005){ref-type="fig"} . The unseeded wastewater samples were used to identify background MHV concentrations in wastewater. Methods A, B and C were derived from virus adsorption extraction methods commonly used to concentrate enteric viruses from water/wastewater ([@bb0210]; [@bb0010]; [@bb0020]). Method A began with acidification of sample to pH 4 using 2 N HCl. Method B did not pre-treat the sample; it began with measuring the pH of the sample (pH = 6.9). Method C began with the addition of MgCl~2~ to the sample to obtain a final concentration of 25 mM MgCl~2~. For Methods A, B and C, samples were then passed through 0.45-μm pore-size, 47-mm diameter electronegative membranes (HAWP04700; Merck Millipore Ltd., Sydney, Australia) via a magnetic filter funnel (Pall Corporation) and filter flask (Merck Millipore Ltd.) ([@bb0010]). The membrane was immediately inserted into a 2 mL-bead beating tube (followed by RNA extraction described below).Fig. 1Virus concentration methods used in this study.Fig. 1

Methods D and E were ultrafiltration methods that use centrifugal devices that have previously been used to concentrate viruses from (waste)water ([@bb0205]; [@bb0100]). Both methods began with the centrifugation of the sample at 4500 *g* for 10 min at 4 °C to obtain a supernatant. For Method D, the supernatant was concentrated using an Amicon® Ultra-15 (molecular weight cut-off 30 kDa) centrifugal filter device (Merck Millipore Ltd.), which was centrifuged at 4750 *g* for 10 min at 4 °C. This centrifugal concentration step was repeated three times to pass through the entire supernatant volume ([@bb0205]; [@bb0100]; [@bb0010]). The concentrated sample (400 μL) was collected from the sample reservoir with a pipette and transferred into a 2 mL-bead beating tube. For Method E, the supernatant was further centrifuged at 3500 *g* for 30 min at 4 °C through the Centricon Plus-70 centrifugal filter device with a molecular weight cut-off of 10 kDa (Merck Millipore). The concentrated sample (300 μL) was collected from the concentrate collection cup with a pipette and mixed with 100 μL of DNase and RNase free water and transferred into a 2 mL-bead beating tube ([@bb0020]; [@bb0145]).

Method F employed PEG precipitation, which is commonly used to concentrate viruses from water matrices ([@bb0155]; [@bb0085]; [@bb0230]). In this study, it began with sample centrifugation at 10,000 *g* for 20 min at 4 °C to remove larger particles and debris. The resulting supernatant was transferred to a fresh centrifuge tube and stored at 4 °C, while MHV was recovered from the pellet. The pellet was re-suspended in beef extract (3% w/v) in 0.05 M glycine (pH 9.0) at a ratio of 1:5. The pellet was agitated on a shaking incubator at 200 rpm for 30 min at room temperature. The pellet suspension was then centrifuged at 10,000 *g* for 10 min at 4 °C and the supernatant was transferred into the centrifuge tube containing supernatant from the initial centrifugation step. The pH of the supernatant mixture was neutralized by the addition of 2 M HCl. PEG 8000 and NaCl were added to the supernatant at ratios of 10% and 2% w/v, respectively. The centrifuge tubes were then incubated at 4 °C for 2 h on an orbital shaker set to 120 rpm. Following incubation, the sample was centrifuged at 10,000 *g* for 30 min at 4 °C to obtain a pellet. The supernatant was discarded, and the pellet was resuspended in 800 μL Trizol (Sigma-Aldrich, Sydney, NSW, Australia). Finally, 400 μL of the concentrated sample was transferred to a 2-mL bead beating tube.

Method G used ultracentrifugation, which is frequently used to concentrate viruses from (waste)water ([@bb0080]; [@bb0250]). In this study, it began with sample centrifugation at 100,000 *g* for 1 h at 4 °C. Supernatant was removed carefully, and the pellet was suspended in 3.5 mL of 0.25 N glycine buffer (pH 9.5). The sample was incubated on ice for 30 min. The sample was neutralized by the addition of 3 mL of 2 × PBS (pH 7.2). The supernatant was clarified by centrifugation (12,000 *g* for 15 min at 4 °C). The virus was recovered by ultracentrifugation at 100,000 *g* for 1 h at 4 °C ([@bb0080]). The pellet was resuspended in 400 μL of 1 × PBS (pH 7.2) and transferred to a 2-mL bead beating tube.

2.4. Viral RNA extraction {#s0030}
-------------------------

Viral RNA was extracted using the RNeasy PowerMicrobiome Kit with a slight modification (Qiagen). The glass beads in the bead tube were replaced with garnet beads which have sharp cutting edges. In brief, a 650 μL of buffer PM1 and 6.5 μL of β-Mercaptoethanol (Sigma-Aldrich) were added into each bead beating tube. Bead beating tubes were homogenized using a Precellys Evolution 24 tissue homogenizer (Bertin Technologies, Montigny-le-Bretonneux, France) at conditions 3 × 20 s at 10,000 rpm at a 10 s interval. Tubes were further centrifuged at 10,000 *g* for 5 min to pellet the filter debris and beads. 450 μL of sample lysate from the bead beating tube was transferred into rotor adapter (Qiagen) using a QIAcube Connect platform (Qiagen) to obtain a final elution volume of 100 μL of RNA. All RNA samples were stored at −80 °C and subjected to RT-qPCR analysis within the same day of RNA extraction to avoid losses associated with storing, as well as freezing and thawing RNA extracts.

2.5. MHV RT-qPCR analyses {#s0035}
-------------------------

A previously published TaqMan-based RT-qPCR assay was used for MHV quantification in the wastewater samples ([@bb2005]). For the MHV RT-qPCR assay, gBlocks gene fragments (double-stranded DNA), containing the 108 bp assay amplicon, were purchased from Integrated DNA Technologies (Coralville, IA, USA). The gBlock containing the MHV assay amplicon was used as a positive control and to generate the standard curve. MHV RT-qPCR analyses were performed in 25 μL reaction mixtures using iTaq™ Universal Probes One-Step Reaction Mix (Bio-Rad Laboratories, Richmond, CA). The MHV RT-qPCR mixture contained 12.5 μL of Supermix, 300 nM of forward primer (5′-GGA ACT TCT CGT TGG GCA TTA TAC T-3′), 300 nM of reverse primer (5′-ACC ACA AGA TTA TCA TTT TCA CAA CAT A-3′), 400 nM of probe (5′-FAM-ACA TGC TAC GGC TCG TGT AAC CGA ACT GT-BHQ-3′), 0.625 μL of iScript RT enzyme and 5 μL of template RNA. The RT-qPCR assays were performed using a Bio-Rad CFX96 thermal cycler (Bio-Rad Laboratories, Richmond, CA), using automatic settings for threshold and baseline. Thermal cycling conditions consisted of RT at 50 °C for 10 min, denaturation and *Taq* polymerase activation at 95 °C for 5 min, and 40 cycles of 95 °C for 15 s followed by 60 °C for 1 min (data collection). RT-qPCR reactions were performed in triplicate for each sample and the sample quantification cycle (Cq) mean was used for further analyses. Samples were always analyzed with corresponding positive (standards) and negative controls (DNase-and RNase-free water).

Separately, three instrument runs were executed on different days to analyze a six-point, ten-fold serial dilution of the MHV assay gBlock (5 × 10^5^ to 5 copies/reaction) in triplicate. A standard curve was generated for each instrument run from the log~10~-linear regression of triplicate Cq values. The lowest number of diluted standards detected in triplicate assays was considered the qPCR assay limit of detection (ALOD). The MHV estimated copy numbers for each virus wastewater concentrate sample were corrected for the difference between the double-stranded standard curve material and the single-stranded MHV virus (i.e., divided by 2).

2.6. Inhibition test {#s0040}
--------------------

The presence of PCR inhibition in virus wastewater concentrate sample RNA was assessed using the *Sketa22* qPCR assay ([@bb2010]) after spiking RNA samples with a known copy number (10^4^/reaction) of *Oncorhynchus keta* (*O. keta*) DNA as described previously ([@bb0020]). In order to determine PCR inhibition, *O. keta* DNA was also added to DNase- and RNase-free water and the mean Cq value was used to set-up a reference point. Subsequently, *Sketa22* qPCR assay (for *O. keta*) was performed in 25 μL reaction mixtures using Bio-Rad CFX96 thermal cycler (Bio-Rad Laboratories), using automatic settings for threshold and baseline. The qPCR assay mixtures contained 12.5 μL of iQ Supermix (Bio-Rad Laboratories), 300 nM of forward primer (5′-GGT TTC CGC AGC TGG G-3′), 300 nM of reverse primer (5'-CCG AGC CGT CCT GGT CTA-3′) 400 nM of probe (FAM-5′AGT CGC AGG CGG CCA CCG T-3′-BHQ), 3 μL of template DNA and a known copy number (10^4^/reaction) of *O. keta* DNA. All samples were analyzed alongside three no template controls. If the Cq value of the RNA sample was \>2-Cq values compared to the reference Cq value for distilled water, the sample was considered to have PCR inhibitors ([@bb0200]; [@bb0015]). All wastewater RNA samples were within the 2-Cq values of the reference Cq value; thus, no qPCR inhibition was identified.

Additionally, the RNA extraction-RT-qPCR process was tested to investigate whether RT-qPCR inhibitors were present using Methods C and D. A 200 μL of MHV suspension was added to a 50-mL aliquot of distilled water and subjected to virus concentration Methods C and D. The reference Cq values obtained for MHV seeded distilled water (for Methods C and D) were compared with the Cq values of the MHV seeded untreated wastewater to obtain information on potential RT-PCR inhibition. Wastewater RNA samples processed with Methods C and D were within the 1 Cq value of the reference Cq value; thus, no evidence of inhibition was identified in the RT-PCR process.

2.7. MHV recovery efficiency {#s0045}
----------------------------

The MHV recovery efficiency of each replicate for each concentration method was calculated based upon the copies quantified per by RT-qPCR as follows:$$\text{Recovery\ Efficiency}\ \left( \% \right) = \frac{\text{Total\ viral}\ {RNA}\ \text{gene\ copies\ recovered}}{\text{Total\ viral}\ {RNA}\ \text{gene\ copies\ seeded}\ } \times 100$$

The mean and standard deviation for each concentration method was calculated.

2.8. Quality control {#s0050}
--------------------

To minimize qPCR contamination, RNA extraction and RT-qPCR set up were performed in separate laboratories. A method blank was included for each concentration method. A reagent blank was also included during nucleic acid extraction to account for any contamination during extraction. All method and extraction blanks were negative for MHV.

2.9. Statistical analysis {#s0055}
-------------------------

The one-way analysis of variance (ANOVA) was used to determine whether there was a difference in MHV recovery among the concentration methods tested and also MHV concentrations in fecal suspensions. Tukey\'s honest significant difference (HSD) test was used for post-hoc evaluation of group pairings that were significantly different (α = 0.05) using GraphPad software (Prism 8.3, La Jolla, CA, USA).

3. Results {#s0060}
==========

3.1. MHV qPCR assay performance {#s0065}
-------------------------------

MHV RT-qPCR standard curves had a dynamic linear range of quantification from 5 × 10^5^ to 5 copies/reaction. The slope of the standard curves ranged from −3.245 to −3.334 ([Table 1](#t0005){ref-type="table"} ). The amplification efficiencies ranged from 98.7 to 103% and the correlation coefficient (*r* ^2^) ranged from 0.992 to 0.995. The ALOQ (i.e., lowest copy number detected 100% of the time) was 5 copies/reaction.Table 1Murine hepatitis virus (MHV) RT-qPCR performance characteristics.Table 1MHV assay runPerformance characteristic (range)Efficiency (E) (%)Linearity (*r*^2^)SlopeY-intercept1103.30.995−3.24539.3232102.40.993−3.25639.564398.70.992−3.33440.124

3.2. MHV concentrations in untreated wastewater and fecal suspension {#s0070}
--------------------------------------------------------------------

RNA was extracted from seven unseeded wastewater virus concentrates to determine the background concentrations of MHV. None of the samples were positive for MHV. The MHV concentration was 5.46 ± 0.20 log~10~ copies/200 μL of fecal suspension as determined by RT-qPCR assay and was used to determine the recovery efficiency of the seven concentration methods examined. The fecal suspension's MHV concentration was not significantly different among replicate analyses (*p* \> .05).

3.3. MHV recovery efficiency from untreated wastewater {#s0075}
------------------------------------------------------

The mean log~10~ copies of MHV recovered/RT-qPCR reaction for each concentration method used in this study are shown in [Table 2](#t0010){ref-type="table"} . For the 50 mL untreated wastewater samples seeded with MHV, Method C (adsorption-extraction method, supplemented with MgCl~2~) provided the highest mean MHV recovery of 65.7 ± 23.0% ([Table 2](#t0010){ref-type="table"}). The second highest mean recovery was for Method B the adsorption-extraction method without pre-treatment. Interestingly, a slightly modified version of this adsorption-extraction method (Method A, adjustment sample pH to 4) recovered less (26.7 ± 15.3%) MHV. Overall, Method D (Amicon Ultra-15 centrifugal filter device) yielded the third-highest mean recovery (56.0 ± 32.3%) of MHV. Method E (Centricon Plus-70 ultrafilter centrifugal device) was similar to Method D, but produced approximately 50% less recovery (28.0 ± 9.10%) of MHV from untreated wastewater samples compared to Method D. Method F (PEG precipitation) provided greater recoveries (44.0 ± 27.7%) than Methods A and E. Methods B and C recovery efficiencies were significantly different (*p* \< .05) than Methods A, E, F and G. Method D recovery efficiency also significantly (*p* \< .05) different than Methods A, E and G.Table 2Mean (±SD) of murine hepatitis virus (MHV) recovered through each concentration method and recovery efficiency of MHV using seven different virus concentration methods (A-G) from untreated wastewater.Table 2Concentration methodsMean ± SD MHV concentration (log~10~ copies of MHV recovered)Mean ± SD of % recovery of MHVMethod A4.85 ± 0.2026.7 ± 15.3Method B5.24 ± 0.0860.5 ± 22.2Method C5.28 ± 0.0965.7 ± 23.8Method D5.13 ± 0.3356.0 ± 32.3Method E4.91 ± 0.0528.0 ± 9.10Method F5.07 ± 0.2144.0 ± 27.7Method G4.98 ± 0.0933.5 ± 12.1[^1]

4. Discussion {#s0080}
=============

There is a need for the development of efficient methods to concentrate and detect SARS-CoV-2 from wastewater, which has been identified as a key research need for WBE ([@bb0115], [@bb0130]). Furthermore, it is important to determine the SARS-CoV-2 concentration method recovery efficiency. First, it can enable the user to select the appropriate method to recover SARS-CoV-2 from wastewater with optimal efficiency. Additionally, characterizing method performance will allow more detailed assessments of the actual SARS-CoV-2 load present in wastewater influent, as well as any given water source receiving (un)treated wastewater. A thorough understanding of SARS-CoV-2 concentration method efficiencies will enable accurate measurements in wastewater and allow public health officials to develop appropriate mitigation strategies needed on a community level. Due to the inherent risks associated with laboratory work with infectious SARS-CoV-2 ([@bb0225]), we used a human CoV surrogate, MHV, belonging to the same genus as SARS-CoV-2 to evaluate concentration method performance. In this study, seven concentration methods were evaluated for their recovery of MHV from wastewater. The benefits and limitations of these methods are summarized in [Table 3](#t0015){ref-type="table"} . These methods have been previously used to recover nonenveloped enteric viruses from various water matrices but have not been evaluated for their ability to detect and concentrate enveloped virus to date except for a few instances ([@bb0190]; [@bb0020]; [@bb0145]; [@bb0230]). When reported, recovery efficiencies for nonenveloped viruses varied widely depending on the matrix and the virus ([@bb0095]), but analogous information for enveloped viruses is not available.Table 3Logistical and theoretical advantages and disadvantages of the virus concentration methods evaluated in this study.Table 3Concentration methodAdvantagesDisadvantagesPotential refinementMethods A, B and C- Rapid (\<40 min to process a sample)\
- Concentrate viruses from both solid and liquid phases.\
- Easy to upscale using 90-mm membranes.\
- Up to 200 mL of sample can be processed, depending on the filter size and turbidity of the sample.\
- Can be undertaken in the field.\
- Only a filtration unit and a pump are required.\
- Multiple samples can be processed at a time if multiple filtration units are available.\
- Easy to store and transport membrane.\
- Relatively inexpensive supplies and generally routine microbial laboratory equipment are required (similar to fecal indicator bacteria membrane filtration methods).- Requires washing and cleaning filtration units.\
- pH adjustment is required (Method A only).\
- Addition of MgCl~2~ is required (Method C only)\
- Clogging may occur due to high turbidity.\
- 90-mm filtration units are expensive.\
- Ideally, a bead-beating system, which is expensive, should be used; however, the RNeasy PowerWater kit (Qiagen) involves a sample homogenizing step that is undertaken with an adaptor and vortex.- Electropositive membrane can also be used.\
- Pre-filter sample to eliminate debris and lower turbidity, which will allow more sample to pass through the filter.\
- Use membrane with a larger pore size (0.8 μm) to process larger volume of wastewater sample.\
- Pre-treating membrane with MgCl~2~ or AlCl~3~ could further increase recovery (Method C only).Methods D and E- Rapid (1 h depending on the turbidity of the sample).\
- The main equipment required is a centrifuge (up to 4,750 *g*).\
- Can process up to 70 mL of sample at a time (Method E only).- Concentrate viruses only from liquid fraction.\
- Ultrafiltration centrifugal unit is expensive.\
- Method D can only process up to 15 mL of sample at a time.\
- Multiple centrifugal units may be needed for high turbidity samples (both Methods D and E).\
- Clogging occurs when turbidity is high.\
- Cannot be used in the field.\
- Viruses adsorb to the membrane, which decreases recovery.\
- Co-concentrates PCR inhibitors.\
- A large, benchtop centrifuge is required, which is expensive.- Use centrifugal unit with 100 kDa filter to speed up the process and reduce clogging.\
- Centriprep (Merck, Millipore) may be an alternative when Centricon is not available.\
- Similar devices can be sourced from other vendors, such as Pall Corporation.Method F- The only equipment required is a centrifuge (up to 10,000 *g*).\
- Concentrate viruses from both solid and liquid phases.\
- Relatively inexpensive.\
- Large volume (e.g., 1 L) of wastewater can be processed.- Time consuming (4-6 h).\
- Requires handling of hazardous chemical (Trizol).\
- Cannot be used in the field.\
- Only a portion of viral concentrate is used to extract RNA, which prohibits the inclusion of all viruses in the sample.- Elute pellet in PBS to reduce hazardous chemical usage.Method G- Concentrate viruses from both solid and liquid phase.\
- The cost per sample is low.- Time consuming (3 h).\
- Only a small number (*n* = 6) of samples can be processed at a time.\
- The sample volume that can be processed is limited (e.g., 50 mL).\
- Requires expensive equipment (ultracentrifuge), which may not be available in a routine microbiology laboratory.\
- Cannot be used in the field.\
- Requires training to operate ultracentrifuge.- Higher centrifugation speeds.

Of the methods tested, two of the adsorption-extraction methods had the most optimal MHV recovery for wastewater samples (Methods B and C) and their mean recovery efficiencies were not significantly different. Adsorption-extraction methods use electronegative membranes with a 0.45-μm pore-size to concentrate viruses; these methods have been used to concentrate nonenveloped viruses in wastewater and environmental waters (as recently reviewed in [@bb0095]; [@bb0035]) and only recently for SARS-CoV-2 ([@bb0160]). The best mean MHV recovery was achieved by Method C, which involved the addition of MgCl~2~ to the wastewater sample prior to filtration. The second highest mean recovery was achieved using Method B, which did not receive any pre-treatment prior to filtration. It is likely that the addition of MgCl~2~ increased MHV adsorption to the filter occurred in Method C. Increased virus adsorption with high MgCl~2~ concentrations was previously described and attributed to salt-bridging ([@bb0220]; [@bb0140]; [@bb0215]; [@bb0105]). Additionally, RT-qPCR inhibitors were not significantly co-concentrated by Method C per comparing the MHV-seeded wastewater and distilled water results.

It is important to note that the adsorption-extraction Methods B and C do not include pre-filtration or centrifugation; thus, they concentrated viruses from the liquid and solid fractions of the wastewater sample. Previous studies have suggested that considerable portions of MHV (and other CoV) may be bound to particulate matter in wastewater because upwards of 26% MHVs were adsorbed to organic matter within the sample ([@bb2015]; [@bb0250]). Since the most efficient MHV concentration methods in this study were those that equally concentrated viruses from the solid and liquid fractions, the present study validates the observation about MHV adsorption to organic matter. Furthermore, the results of the present study highlight the need to concentrate both liquid and solid fractions of wastewater samples. Interestingly, Method A (adsorption-extraction, with acidification pre-treatment) also concentrated both fractions of the sample, but unlike Methods B and C, it required acidification of the sample to pH 4 and yielded the lowest recoveries. It has been reported that sample acidification might affect virus integrity and infectivity ([@bb0005]; [@bb0185]). This suggests that, unlike other enteric viruses, CoV may be sensitive to low pH. Further cross-comparison may be required to identify the impacts of acidification and other pre-treatment on the recovery of SARS-CoV-2 from untreated wastewater samples.

We found that ultrafiltration using centrifugal concentration devices may also be suitable for the recovery of MHV; however, recovery efficiency varied greatly based upon the centrifugal concentration device utilized (Methods D and E). Ultrafiltration using centrifugal concentration devices concentrate viruses based on size exclusion rather than electrostatic interactions between negatively charged viruses and electronegative or electropositive membranes. In this method, molecules smaller than the molecular weight cut-off are passed through the membrane by centrifugation; thus, the viruses are collected in the retentate fraction. These methods have been previously used to concentrate viruses from (waste)water ([@bb0205]; [@bb0100]) and recently used for SARS-CoV-2 RNA detection in untreated wastewater ([@bb0020]; [@bb0145]; [@bb0120]). Overall, Method D (Amicon Ultra-15 centrifugal filter device) yielded the third-highest recovery, while Method E (Centricon Plus-70 centrifugal concentration device) had the second worst MHV recovery. The significantly different (*p* \< .05) MHV recovery efficiencies between the two different types of centrifugal concentration devices demonstrate that not all centrifugal devices can effectively concentrate CoV from wastewater.

The difference in recovery efficiency could be due to differences in design. The Centricon plus-70 unit has a greater surface area for filtration than the Amicon Ultra-15 centrifugal filter device; thus, more MHV could have been lost via adsorption to the membrane via van der Waals interactive forces and/or hydrophobic bonding ([@bb0105]). [@bb0100] used 30 kDa Centricon ultrafiltration units in a secondary concentration step following electropositive NanoCeram cartridge filters. The Centricon recovered 75% of MS2 coliphage, 61% of Echovirus 1, 95% of Poliovirus 1, and 109% of Coxsackievirus B5; however, only 33% of adenovirus 2 was recovered. Adenovirus recovery was similar to that obtained for MHV in our study. Such results suggest that a given centrifugal concentration device may also yield variable recoveries for different classes of viruses.

In addition to not being the most efficient method for MHV recovery, ultrafiltration using centrifugal concentration devices has a variety of drawbacks. One limitation is that a pre-filtration step at low speed is required to remove most of the larger debris and cells before ultrafilter centrifugation. Such pre-filtration can cause the loss of particle-associated viruses in the pellet. The resultant pellets from Methods D and E were analyzed for MHV in our study; we observed \~30% loss of MHV during the pre-filtration step. Furthermore, Method D is time-consuming because the maximum sample volume of these units is 15 mL; hence, repeated centrifugation of 15--20 mL aliquots is required to concentrate a 50-mL sample. While no evidence of RT-qPCR inhibition was identified in this study using Method D, these centrifugal concentration devices may co-concentrate PCR inhibitors. Furthermore, smaller molecular cut-off (i.e., 10 kDa or 30 kDa) device will take significant longer time to process wastewater samples than larger molecular cut-off (i.e., 100 kDa) and also co-concentrate different levels of PCR inhibitors. Finally, centrifugal concentration devices are quite expensive and often not readily available in many countries.

Thus, adsorption-extraction methods (Methods B and C) may be more logistically feasible and efficient for SARS-CoV-2 WBE. Method F (PEG precipitation) appeared to be a promising approach for MHV concentration because it incorporated the concentration of viruses from both the liquid and solid fractions of wastewater, however; it recovered significantly less MHV in comparison to Methods B and C. Different versions of PEG precipitation have been used for the assessment of SARS-CoV-2 in untreated wastewater, but the efficiencies were not reported ([@bb0230]; [@bb0120]; [@bb0260]; Bar-or et al., 2020). To the best of our knowledge, only one study reported the MHV recovery (\~5%) using PEG precipitation ([@bb0250]), which was much lower than the value obtained in this study. This is likely because in our study PEG method concentrated MHV from both liquid and solid fractions, whereas in the previous study MHV was concentrated only from liquid phase ([@bb0250]). Using PEG precipitation methods, [@bb0120] found 1--1.5 log~10~-reduction in detection due to RT-qPCR inhibition when using this method and it is likely that the co-concentration of inhibitors with these methods explained their lower MHV recoveries. While qPCR inhibition was not observed in our study, the RT process may have been inhibited.

In this study, Method G (ultracentrifugation) yielded a mean recovery of 33.5%, which was significantly less than the most efficient methods (Methods B and C). [@bb0235] used ultracentrifugation to recover SARS-CoV-2 from 11 mL of wastewater but did not provide recovery efficiency data. Ultracentrifugation has been used for decades to concentrate viruses from environmental matrices. It has been reported that ultracentrifugation at 100,000 *g* is required to pellet most macromolecules and viruses (Ammersbach and Bienzle, 2011). For example, [@bb0080] reported that ultracentrifugation (100,000 *g* for 1 h at 4 °C) had a mean recovery of 47% (range of 34--60%) of nonenveloped rotavirus A from wastewater samples. [@bb0250] seeded 60 mL of wastewater with MHV and with the nonenveloped MS2 coliphage. Low mean recoveries (\~5%) were achieved for both MHV and MS2 using the ultracentrifugation method; however, analyses were culture-based, and authors attributed low MHV and MS2 recoveries to virus inactivation by the high *g* force of the ultracentrifugation. The method also involves discarding supernatant a few times which may have resulted in loss of MHV. Nevertheless, this method may not be suitable for WBE studies because it requires expensive specialized centrifuges that may not be found in all laboratories.

This study is the first to evaluate established wastewater virus concentration methodologies for their use to concentrate CoV from wastewater, and ultimately, facilitate WBE. Since free viral RNA can degrade within minutes in wastewater ([@bb0135]), most of the RNA copies detected in the wastewater virus concentration methods will be most likely from intact virus particles that may or may not be infectious. While we identified superior performance by the adsorption extraction concentration methods, with MgCl~2~ pre-treatment and without pre-treatment, it is important to note that the methods performance evaluation was based on small volumes (50 mL) of one municipal WWTP and the use of a surrogate (MHV). It is possible that CoV recovery efficiencies may vary based upon the wastewater matrix characteristics (e.g., concentration of total and dissolved suspended solids).

Frequently, it is possible to filter as much as 100--200 mL of wastewater using the adsorption extraction method used in this study. If these larger volumes were filtered, then the adsorption-extraction methods may become less efficient given the increased co-concentration of inhibitors. Also, centrifugal concentration devices, such as those used in this study, may co-concentrate RT-PCR inhibitors. To obtain information on the RT-PCR inhibitors, 50 mL of distilled water was seeded with MHV and the MHV recovery efficiency was compared to that for the MHV seeded wastewater for Methods C and D. Given that the recovery efficiency was only improved for distilled water by 5--8%, it is unlikely that 50 mL wastewater samples tested in this study had RT-PCR inhibitors. It is likely that the co-concentration of inhibitors from larger volumes will have a minimal influence on CoV recovery but will require further investigation. Furthermore, RNA extraction kit used in this study is equipped with next-generation inhibition removal technology (IRT) which is designed to remove PCR inhibitors effectively for soil and fecal samples.

Several methods identified in this preliminary study can be used in conjunction with large-scale primary concentration procedures (2--100 L, such as dead-end or tangential flow hollow fibre ultrafiltration) as a primary step to reduce filter elution to volumes, which are applicable to molecular detection assays. Furthermore, the focus of future research efforts should be to compare recovery efficiencies of MHV to those of actual SARS-CoV-2, considering the multiple benefits of working with the former as a surrogate. Also, the recovery efficiency of various levels of surrogate CoV or SARS-CoV-2 from large volumes of wastewater needs to be assessed to better understand how these variabilities affect recovery efficiency. Furthermore, the best methods for the recovery of intact virus particles need to be identified. Given the high standard deviations observed in the recoveries of any given method, the use of a process control is highly recommended for assessing and normalizing SARS-CoV-2 concentrations for WBE. MHV is a promising process control, which can be purchased from ATCC® VR-764™ and similar companies; however, it may be difficult to obtain this virus in a timely-manner during the pandemic. Other coronaviruses, and/or other viral surrogates, could also be useful process controls for SARS-CoV-2 surveillance; thus, future studies are needed to assess their use as a process control. The culmination of these efforts will aid public health officials, epidemiologist and modellers in assessing incidences of SARS-CoV-2 infection rates at the community scale using WBE approaches, so that appropriate public health response and intervention strategies are deployed.
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[^1]: 5.46 ± 0.20 log~10~ copies were seeded; SD: Standard deviation.
